We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRPH market cap is 15.35M. The company's latest EPS is USD -1.2846 and P/E is -0.28.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.63M | 2.47M | 3.15M | -2.48M | 1.43M |
| Operating Income | -8.3M | -7.83M | -7.94M | -14.57M | -3.66M |
| Net Income | -6.27M | -6.15M | -6.59M | -34.36M | 3.97M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 14.51M | 79.04M | 122.65M | 44.38M | 6.77M |
| Operating Income | -3.99M | 9.8M | 23.6M | -21.61M | -38.63M |
| Net Income | -2.13M | 6.27M | 18.46M | -16.78M | -53.36M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 90.03M | 93.68M | 91.81M | 63.2M | 50.11M |
| Total Liabilities | 45.17M | 49.6M | 53.68M | 55.85M | 34.99M |
| Total Equity | 44.87M | 44.08M | 38.13M | 7.35M | 15.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 31.41M | 89.3M | 87.65M | 91.93M | 63.2M |
| Total Liabilities | 20.85M | 30.67M | 24.02M | 42.54M | 55.85M |
| Total Equity | 10.56M | 58.63M | 63.63M | 49.38M | 7.35M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.12M | -9.94M | -13.97M | -17.54M | -3.38M |
| Investing | 2.44M | 2.56M | 2.46M | 2.42M | 853k |
| Financing | 2.27M | 7.59M | 10.45M | 14.19M | 1.94M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.59M | -13.62M | 28.55M | -11.35M | -17.54M |
| Investing | -1.02M | -19.67M | -2.08M | -1.37M | 2.42M |
| Financing | 9.99M | 35.13M | -26.02M | 5.76M | 14.19M |
| Market Cap | 15.35M |
| Price to Earnings Ratio | -0.28 |
| Price to Sales Ratio | 2.21 |
| Price to Cash Ratio | 22.09 |
| Price to Book Ratio | 2.03 |
| Dividend Yield | - |
| Shares Outstanding | 41.54M |
| Average Volume (1 week) | 595.32k |
| Average Volume (1 Month) | 805.52k |
| 52 Week Change | -88.60% |
| 52 Week High | 3.3654 |
| 52 Week Low | 0.2179 |
| Spread (Intraday) | 0.01 (1.98%) |
| Company Name | ProPhase Labs Inc |
| Address |
874 walker road dover, delaware 19904 |
| Website | https://www.prophaselabs.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
